Everything Heads, PIs, Scientists and Engineers need to know to streamline upstream cell culture processes cost-efficiently
Optimizing upstream cell culture – a $25M market by 2018
Upstream cell culture is the single, most critical process in developing safe and efficacious biologics and vaccines; the therapies of the future for unmet medical needs. Yet it is volatile as it is expensive since it depends on living material for cure.
This 4th annual Cell Culture World Congress USA is part of Terrapinn’s cell culture global series that brings together Heads, Principal Investigators, Scientists and Engineers from biopharmaceutical companies’ upstream cell culture divisions, to share and learn from each other novel and innovative strategies to streamline and manage cell culture processes better.
Innovative cell culture equipment providers along with cell culture sera, media and reagents companies who have solutions to offer join in. If you have a technology or process to optimize cell culture, be sure to join us in May 2015 in San Diego